The world is bracing for the impact of the novel coronavirus, COVID-19, which has now spread to over 30 countries, infecting more than 80,000 people with over 2,600 deaths globally.
The world is bracing for the impact of the novel coronavirus, COVID-19, which has now spread to over 30 countries, infecting more than 80,000 people with over 2,600 deaths globally.
n article by radiologists from Wuhan, China--published open-access and ahead-of-print in the American Journal of Roentgenology (AJR)--concluded that chest CT had a low rate of misdiagnosis of COVID-19 (3.9%, 2/51) and could help standardize imaging features and rules of transformation for rapid diagnosis; however, CT remains limited for the identification of specific viruses and distinguishing between viruses.
University of Texas System researchers have pinpointed a molecule that the tuberculosis bacterium manufactures to induce the coughing that spreads the disease by triggering a pain-receptor response. Their findings illustrate that the disease's spread might be prevented by halting production of sulfolipid-1.
Faculty Q&AAs the coronavirus spreads throughout the country, an increasing number of American health care workers helping to treat patients are contracting the infection.Christopher Friese.Christopher Friese, the Elizabeth Tone Hosmer Professor of Nursing at the School of Nursing and professor of health management and policy at the School of Public Health, leads a research team focused on health care delivery in high-risk settings.
A first-of-its-kind survey conducted by the Pulmonary Fibrosis Foundation (PFF) reveals that a vast majority of Americans (86%) do not know the symptoms of pulmonary fibrosis (PF). While 50,000 new cases are diagnosed annually, the disease remains largely unknown. There is no cure.
Leading up to Earth Day on April 22, Cedars-Sinai is posting a weekly story and video that investigates the various ways climate change is impacting our bodies. This week's topic: The Lungs and Climate Change.
A multi-center study (n=101) of the relationship between chest CT findings and the clinical conditions of coronavirus disease (COVID-19) pneumonia--published ahead-of-print and open-access in the American Journal of Roentgenology (AJR)--determined that most patients with COVID-19 pneumonia have ground-glass opacities (GGO) (86.1%) or mixed GGO and consolidation (64.4%) and vascular enlargement in the lesion (71.3%).
With the help of a $1.98 million award from the NIH, Wayne State University researchers are working to develop biomarker technology for identification of biomarkers of sarcoidosis, an inflammatory disease of unknown causes that affects multiple organs in the body.
.ROCKVILLE, MD – As concern continues to grow concerning the novel coronavirus, COVID-19, so does the opportunity for misinformation to spread as the public searches for reliable information on infection and means of protection.
A new culprit — hydrogen sulfide — worsens the deadly disease tuberculosis. When Tb bacteria invade the lung, the amounts of hydrogen sulfide in the lung microenvironment greatly increase, and this makes the microbe more virulent and better able to block the body’s protective immune response.
While COVID-19, previously known as the novel coronavirus, was first reported in China, it was recently declared a global health emergency by the World Health Organization. Because most cases have been in China, clinicians elsewhere may be unfamiliar with how the virus appears in the lungs.
Polling locations across the country employ different methods of casting ballots, like using pens, felt-tip markers or touch screens — all hotbeds for germs.
An international team of clinicians and researchers for the first time have described the pathology of the SARS-CoV-2, or coronavirus, and published their findings in the Journal of Thoracic Oncology, the journal of the International Association for the Study of Lung Cancer.
Emergency physician-led teams are on the frontlines of coronavirus treatment, prevention and response.
The emergence and rapid increase in cases of coronavirus disease 2019 (COVID-19), a respiratory illness caused by a novel coronavirus, pose complex challenges to the global public health, research and medical communities, write federal scientists from NIH's National Institute of Allergy and Infectious Diseases (NIAID) and from the Centers for Disease Control and Prevention (CDC).
Although the imaging features of novel coronavirus disease 2019 (COVID-19) are variable and nonspecific, the findings reported thus far do show "significant overlap" with those of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), according to an ahead-of-print article in the American Journal of Roentgenology (AJR).
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right